Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

Delayed Data
As of 4:00pm ET
 -0.105 / -0.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Y-mAbs Therapeutics Inc have a median target of 26.00, with a high estimate of 63.00 and a low estimate of 16.00. The median estimate represents a +81.88% increase from the last price of 14.30.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Y-mAbs Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.49%
Growthannually -86.52%


Growthquarterly 28.59%
Growthannually 52.00%
Key to the earnings and sales forecast charts.